Study uncovers biological drivers of plasma proteins, offering new insights for disease biomarkers and drug discovery

Bluebird won approval with the FDA for its gene therapy Zynteglo (betibeglogene autotemcel) last year to treat beta thalassaemia. Credit: Gorodenkoff via Shutterstock. bluebird bio‘s

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

Last week, it was reported that an infant died from a Listeria infection in an outbreak tied to ready-to-eat-meat products. Meanwhile, recalls continue after an